Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-08-09
2009-02-10
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S106000, C544S111000, C544S124000, C514S231200, C514S231500, C514S235500
Reexamination Certificate
active
07488728
ABSTRACT:
The invention relates to compounds of formula (I):wherein R, R1, R2and X are defined herein, their preparation, and their use as pharmaceuticals.
REFERENCES:
patent: 7294623 (2007-11-01), Clark et al.
patent: 2 060 622 (1981-05-01), None
patent: 2 167 407 (1986-05-01), None
patent: WO 99/15177 (1999-04-01), None
patent: WO 00/39091 (2000-07-01), None
patent: WO 01/01973 (2001-01-01), None
patent: WO 03/106441 (2003-12-01), None
patent: WO 2004/017977 (2004-03-01), None
patent: WO 2004/018440 (2004-03-01), None
International Search Report.
Thornber C.W., “Isosterism and Molecular Modification in Drug Design”,Chemical Society Reviews, vol. 8, No. 4, 1979, pp. 563-580.
Clark Barry Peter
Gallagher Peter Thaddeus
Cohen Charles E.
Eli Lilly and Company
Shameem Golam M
LandOfFree
Pyridinylmorpholine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridinylmorpholine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridinylmorpholine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4092771